These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15781479)

  • 1. Idiopathic urinary stone disease: possible polygenic aetiological factors.
    Watts RW
    QJM; 2005 Apr; 98(4):241-6. PubMed ID: 15781479
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary kidney stone inhibitors. Where are we?
    Dussol B; Berland Y
    Nephrol Dial Transplant; 1996 Jul; 11(7):1222-4. PubMed ID: 8672008
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exclusion mapping of major crystallization inhibitors in idiopathic calcium urolithiasis.
    Cailhier JF; Petrucci M; Valiquette L; Guay G; Ouimet D; Bonnardeaux A
    J Urol; 2001 Oct; 166(4):1484-6. PubMed ID: 11547117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men.
    Marengo SR; Resnick MI; Yang L; Chung JY
    J Urol; 1998 May; 159(5):1444-50. PubMed ID: 9554330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
    Atmani F; Mizon J; Khan SR
    Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inter-alpha-inhibitor and several of its derivatives on calcium oxalate crystallization in vitro.
    Dean C; Kanellos J; Pham H; Gomes M; Oates A; Grover P; Ryall R
    Clin Sci (Lond); 2000 Apr; 98(4):471-80. PubMed ID: 10731483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins.
    Grover PK; Moritz RL; Simpson RJ; Ryall RL
    Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney.
    Atmani F; Glenton PA; Khan SR
    Urol Res; 1999; 27(1):63-7. PubMed ID: 10092155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.
    Ryall RL
    Pediatr Nephrol; 1996 Oct; 10(5):656-66. PubMed ID: 8897580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitors in calcium oxalate crystals].
    Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):411-20. PubMed ID: 10349299
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a functional proteinase inhibitor capable of accepting xylose: bikunin.
    Falkenberg C; Wester L; Belting M; Eklund E; Akerström B
    Arch Biochem Biophys; 2001 Mar; 387(1):99-106. PubMed ID: 11368189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic factors in calcium oxalate stone disease.
    Goodman HO; Holmes RP; Assimos DG
    J Urol; 1995 Feb; 153(2):301-7. PubMed ID: 7815569
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.
    Stapleton AM; Ryall RL
    Br J Urol; 1995 Jun; 75(6):712-9. PubMed ID: 7613825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease.
    Stapleton AM; Timme TL; Ryall RL
    Br J Urol; 1998 May; 81(5):666-71; discussion 671-2. PubMed ID: 9634038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of calcium phosphate-associated proteins on calcium oxalate crystallization: alpha2-HS-glycoprotein, prothrombin-F1 and osteopontin.
    Nishio S; Iseda T; Takeda H; Iwata H; Yokoyama M
    BJU Int; 2000 Sep; 86(4):543-8. PubMed ID: 10971289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uromucoids and urinary stone formation.
    Hallson PC; Rose GA
    Lancet; 1979 May; 1(8124):1000-2. PubMed ID: 86719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.